December 12, 2023 – Myos Corp, an innovation-driven medical nutrition company, announced that it has been awarded US Patent No 11,833,186 for its signature proprietary product, Fortetropin – further cementing its science-backed claims to enhance mobility and activity in aging canines.
Fortetropin is the key ingredient in Myos Canine Muscle Formula, an all-natural dietary supplement that has been shown by eight published peer-reviews clinical studies to have tremendous muscle health efficacy in mammals. The new patent, Myos Corp’s eighth to date, specifically addresses the use of Fortetropin in treating canine muscle loss in conditions such as rheumatoid arthritis, osteoarthritis and hip dysplasia, while also improving mobility and activity levels and reducing lean body mass wasting.
You may also be interested in:
With this patent now in place, Myos has an even clearer runway as a wholly-unique, all natural, clinically proven supplement in the rapidly-growing and increasingly competitive animal health industry.
“Myos stand out in protecting our innovative products with patents backed by clinically validated, peer-review studies,” said Myos Corp CEO Joe Mannello. “We’re gratified that the US Patent Office continues to recognise the distinctiveness and effectiveness of Fortetropin, granting us robust patent protection.”
While numerous pet supplement brands claim an ability to enhance joint health as a way to combat the symptoms of aging, Myos stands alone as the only company to offer a unique, clinically proven product to address muscle health. With eight published clinical studies and now eight US patents, Myos continues to build an impressive IP Portfolio that acts as a powerful separator from its competitors.
The global pet supplement market is experiencing rapid growth, reflecting a broader trend in pet care toward health and longevity. This expansion is particularly pronounced in the realm of senior dog care, where a growing number of products are being developed and marketed specially for aging canines. This segment’s growth is fuelled by pet owners’ increasing willingness to invest in their pets’ health, akin to how they care for human family members.
For more information, visit HERE.
